Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cullinan Therapeutics Inc | CGEM | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 23.81 | 04:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 23.81 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 7.64 - 30.1886 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 23.81 | USD |
Cullinan Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.03B | 43.07M | - | 0 | -153.16M | -3.56 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cullinan Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CGEM Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 27.30 | 28.19 | 23.18 | 25.80 | 705,006 | -3.49 | -12.78% |
| 1 Month | 18.00 | 30.1886 | 15.20 | 24.64 | 1,275,780 | 5.81 | 32.28% |
| 3 Months | 17.59 | 30.1886 | 14.98 | 21.43 | 753,787 | 6.22 | 35.36% |
| 6 Months | 9.06 | 30.1886 | 7.64 | 18.82 | 531,387 | 14.75 | 162.80% |
| 1 Year | 9.13 | 30.1886 | 7.64 | 16.28 | 384,407 | 14.68 | 160.79% |
| 3 Years | 27.59 | 37.60 | 7.30 | 15.87 | 300,145 | -3.78 | -13.70% |
| 5 Years | 42.00 | 59.85 | 7.30 | 18.12 | 298,082 | -18.19 | -43.31% |
Cullinan Therapeutics Description
| Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. |
